Pharmesis International Ltd. (SG:BFK) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Pharmesis International Ltd. has announced the appointment of Ms Li Li Jie as an Independent Non-Executive Director, effective from 31 May 2024. She will also serve on the Audit, Nominating, and Remuneration Committees of the firm. This addition comes as part of a reshuffling that affects the composition of the Board and its Committees, aimed at enhancing the company’s governance and oversight.
For further insights into SG:BFK stock, check out TipRanks’ Stock Analysis page.